The survival rate of mid-stage cervical cancer is about 30%-50%. The metastatic route of cervical cancer is more common through direct spread and hematogenous metastasis. When cervical cancer reaches the middle stage, if there are metastasis to the vaginal wall, uterine body and parametrial tissues, radiotherapy and chemotherapy should be given to shrink the tumor cells before surgery, and radiotherapy and chemotherapy should be continued after surgery, and the effect is better. The survival rate of mid-stage cervical cancer is based on the sensitivity of tumor cells to chemotherapy drugs, recurrence and other factors. When women have cervical cancer surgery, they must regularly review tumor markers, chest X-ray, gynecological ultrasound and other examinations to detect the metastasis of malignant cells at an early stage and take symptomatic treatment as early as possible in order to improve the survival rate of patients.